Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (8)

Trial Status

Recruiting4
Active Not Recruiting3
Unknown3
Not Yet Recruiting3
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07572968RecruitingPrimary

Dual-Task Effects on Gait and Balance in MCRS

NCT07572942RecruitingPrimary

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

NCT07554027Not ApplicableNot Yet Recruiting

Effect of Episodic Future Thinking on Promoting Physical Activity Among Older Adults With Motoric Cognitive Risk Syndrome: A Randomized Controlled Trial

NCT07045259Not ApplicableRecruitingPrimary

Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome

NCT07223905Not ApplicableNot Yet RecruitingPrimary

Motor-Cognitive Training for Motoric Cognitive Risk Syndrome

NCT06451874Not ApplicableRecruitingPrimary

Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome

NCT06581458Not ApplicableNot Yet RecruitingPrimary

Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome

NCT04275817Active Not Recruiting

Cognitive Prefrail and Frailty, and Motoric Cognitive Risk Syndrome: Prevalence and Association With Incident Adverse Health Events

NCT05046275Active Not RecruitingPrimary

MCR Syndrome in Quebec : Results From NuAge Study

NCT04240028Active Not Recruiting

The Cognitive-Prefrail Syndrome and Its Association With Adverse Health Outcomes

NCT05640141UnknownPrimary

Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

NCT03750682Not ApplicableCompletedPrimary

ENGAGE for Brain Health

NCT04492241Not ApplicableUnknownPrimary

Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome

NCT04115215Not ApplicableUnknown

Pre-FRONTal Brain STability, Key for Action Against Disability in AGing

Showing all 14 trials

Research Network

Activity Timeline